Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Thank you for selecting your broker
We are redirecting you to the Broker Center now
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
Thank you for your submission, we hope you enjoy your experience
ALERT

FREE Webinar for FA’s and RIA’s — Reserve Your Seat Now!

Mutualfunds logo

SHSCX BlackRock Health Sciences Opps Inv C

  • Fund
  • SHSCX
  • Price as of: Dec 01, 2016
  • $40.65
  • - $0.33
  • - 0.81%
  • Category
  • Health & Biotech Equities

SHSCX - Profile

Vitals

  • YTD Return -7.1%
  • 3 Yr Annualized Return 10.8%
  • 5 Yr Annualized Return 17.3%
  • Net Assets $5.08 B
  • Holdings in Top 10 36.0%

52 WEEK LOW AND HIGH

$40.65
$36.68
$48.95

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.88%

SALES FEES

  • Front Load N/A
  • Deferred Load 1.00%

BROKERAGE FEES

  • Turnover 50.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$1,000

IRA

$100

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return -7.1%
  • 3 Yr Annualized Total Return 10.8%
  • 5 Yr Annualized Total Return 17.3%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.90%
DIVIDENDS
  • Dividend Yield N/A
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name BlackRock Health Sciences Opportunities Portfolio
  • Fund Family Name BlackRock
  • Inception Date Oct 16, 2000
  • Shares Outstanding N/A
  • Share Class C
  • Currency USD
  • Domiciled Country United States
  • Manager Erin Xie

Fund Description

The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries. The fund is non-diversified.

SHSCX - Performance

Return Ranking - Trailing

Period SHSCX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -7.1% -30.9% 7.4% 25.89% 2
1 Yr -5.7% -31.1% 18.4% 16.22% 1
3 Yr 10.8% * -17.6% 17.2% 13.89% 1
5 Yr 17.3% * -5.6% 21.9% 26.73% 2
10 Yr 11.4% * -2.7% 14.3% 23.86% 2

* Annualized


Return Ranking - Calendar

Period SHSCX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 -3.3% -20.4% 13.8% 57.27% 3
2014 19.5% -5.9% 31.5% 30.91% 2
2013 29.5% 0.0% 65.2% 72.48% 4
2012 9.6% -5.3% 36.5% 69.90% 4
2011 0.1% -15.5% 18.8% 56.86% 3

Total Return Ranking - Trailing

Period SHSCX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -7.1% -23.6% 7.4% 26.13% 2
1 Yr -6.5% -30.7% 10.5% 20.91% 2
3 Yr 10.8% * -17.6% 19.3% 29.63% 2
5 Yr 17.3% * -5.6% 147.5% 53.54% 3
10 Yr 11.4% * -2.3% 37.3% 47.06% 3

* Annualized


Total Return Ranking - Calendar

Period SHSCX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 -3.3% -16.6% 20.7% 88.99% 5
2014 30.5% -5.8% 55.3% 63.30% 4
2013 56.0% 0.0% 398.7% 85.19% 5
2012 26.9% -5.1% 475.8% 81.00% 5
2011 8.1% -10.2% 2296.2% 63.92% 4

NAV & Total Return History

SHSCX - Holdings

Filings data as of: Oct 31, 2016

Concentration Analysis

SHSCX Category Low Category High SHSCX % Rank Quintile
Net Assets 5.08 B 20.5 M 43.6 B 5.36% 1
Number of Holdings 106 31 345 11.61% 2
Net Assets in Top 10 1.83 B 9.55 M 20.9 B 6.25% 1
Weighting of Top 10 36.0% 21.8% 71.5% 26.79% 4

Top 10 Holdings

  1. UnitedHealth Group Inc 6.47%
  2. Medtronic PLC 5.55%
  3. Eli Lilly and Co 2.72%
  4. Allergan PLC 2.87%
  5. Boston Scientific Corp 3.88%
  6. Amgen Inc 3.82%
  7. Johnson & Johnson 2.85%
  8. Pfizer Inc 2.76%
  9. Baxter International Inc 2.59%
  10. Stryker Corp 2.48%

Asset Allocation

Weighting Category Low Category High SHSCX % Rank Quintile
Stocks
90.74% 82.12% 103.35% 32.14% 5
Cash
8.22% 0.00% 16.35% 1.79% 1
Other
1.04% -3.35% 10.27% 9.82% 2
Convertible Bonds
0.00% 0.00% 0.38% 3.57% 1
Preferred Stocks
0.00% 0.00% 0.96% 4.46% 2
Bonds
0.00% 0.00% 1.91% 5.36% 1

Stock Sector Breakdown

Weighting Category Low Category High SHSCX % Rank Quintile
Healthcare
89.72% 13.15% 99.87% 26.79% 4
Technology
0.77% 0.00% 64.83% 18.75% 3
Consumer Cyclical
0.26% 0.00% 3.21% 2.68% 1
Financial Services
0.00% 0.00% 1.00% 6.25% 2
Real Estate
0.00% 0.00% 1.97% 2.68% 1
Industrials
0.00% 0.00% 13.35% 12.50% 3
Energy
0.00% 0.00% 0.00% 0.89% 1
Communication Services
0.00% 0.00% 1.73% 1.79% 1
Consumer Defense
0.00% 0.00% 2.38% 12.50% 3
Utilities
0.00% 0.00% 1.10% 1.79% 1
Basic Materials
0.00% 0.00% 4.92% 4.46% 2

Stock Geographic Breakdown

Weighting Category Low Category High SHSCX % Rank Quintile
US
85.60% 60.81% 99.87% 20.54% 3
Non US
5.14% 0.00% 41.10% 24.11% 4

SHSCX - Expenses

Operational Fees

SHSCX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 1.88% 0.10% 4.31% 19.64% 4
Management Fee 0.68% 0.08% 1.25% 12.50% 2
12b-1 Fee 1.00% 0.00% 1.00% 1.28% 4
Administrative Fee 0.04% 0.01% 0.40% 15.38% 2

Sales Fees

SHSCX Fees (% of AUM) Category Low Category High SHSCX Rank Quintile
Front Load N/A 3.50% 5.75% N/A N/A
Deferred Load 1.00% 1.00% 5.00% 12.50% 1

Trading Fees

SHSCX Fees (% of AUM) Category Low Category High SHSCX Rank Quintile
Max Redemption Fee N/A 0.75% 2.00% N/A N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

SHSCX Fees (% of AUM) Category Low Category High SHSCX Rank Quintile
Turnover 50.00% 7.00% 249.00% 14.29% 3

SHSCX - Distributions

Dividend Yield Analysis

SHSCX Category Low Category High SHSCX % Rank Quintile
Dividend Yield N/A 0.01% 0.94% N/A N/A

Dividend Distribution Analysis

SHSCX Category Low Category High Category Mode
Dividend Distribution Frequency Quarterly Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

SHSCX Category Low Category High SHSCX % Rank Quintile
Net Income Ratio -0.90% -2.22% 1.40% 51.79% 4

Capital Gain Distribution Analysis

SHSCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

SHSCX - Managers

Erin Xie

Manager

Start Date

Jul 31, 2003

Tenure

13.26

Tenure Rank

5.2%

Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.


Thomas P. Callan

Lead Manager

Start Date

Jan 31, 2005

Tenure

11.76

Tenure Rank

6.1%

Thomas P. Callan, CFA, Managing Director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He oversees the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. In addition, Mr. Callan is a member of BlackRock's Leadership Committee. Mr. Callan's service with the firm dates back to 1988, including his years with PNC Asset Management Group, which was integrated with BlackRock in 1998. He started as a health care analyst for PNC's mutual fund group and later served as an international equity analyst. Mr. Callan began his investment career at PNC Bank as a personal trust portfolio manager in 1988. Mr. Callan earned a BA degree in economics, with honors, from Boston College in 1981.


Tenure Analysis

Category Low

0.0

Category High

19.1

Category Average

8.78

Category Mode

4.8